New medicinal product based on heparin which can be administered by tracheo - lung and alveolar

摘要

P the invention relates to a new product based on heparin administered by trach - lung and cellular. This new product is characterized by the fact that it consists of an aqueous solution of heparin and of at least one chemical agent or natural known to increase the permeability of the trach - bronchial mucosa alveolar and / p & & p & application in the form of aerosol at doses of 5 000 to 100 000 iu for the treatment of thromboembolic events, the atherosclerosis, myocardial infarction, acute thrombosis, arterial embolism, phlebitis. / p